These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1468155)

  • 1. Isolation of acylcarnitines from urine: a comparison of methods and application to long-chain acyl-CoA dehydrogenase deficiency.
    Morrow RJ; Rose ME
    Clin Chim Acta; 1992 Oct; 211(1-2):73-81. PubMed ID: 1468155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.
    Roe CR; Millington DS; Maltby DA; Bohan TP; Kahler SG; Chalmers RA
    Pediatr Res; 1985 May; 19(5):459-66. PubMed ID: 4000772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of plasma acylcarnitines using gas chromatography chemical ionization mass fragmentography.
    Costa CG; Struys EA; Bootsma A; ten Brink HJ; Dorland L; Tavares de Almeida I; Duran M; Jakobs C
    J Lipid Res; 1997 Jan; 38(1):173-82. PubMed ID: 9034211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.
    Costa CG; Dorland L; de Almeida IT; Jakobs C; Duran M; Poll-The BT
    J Inherit Metab Dis; 1998 Jun; 21(4):391-9. PubMed ID: 9700596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
    Chalmers RA; Roe CR; Stacey TE; Hoppel CL
    Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of carnitine and specific acylcarnitines by high-performance liquid chromatography: application to normal human urine and urine from patients with methylmalonic aciduria, isovaleric acidemia or medium-chain acyl-CoA dehydrogenase deficiency.
    Minkler PE; Hoppel CL
    J Chromatogr; 1993 Apr; 613(2):203-21. PubMed ID: 8491807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acylcarnitine profiles during carnitine loading and fasting tests in a Japanese patient with medium-chain acyl-CoA dehydrogenase deficiency.
    Yokoi K; Ito T; Maeda Y; Nakajima Y; Ueta A; Nomura T; Koyama N; Kato I; Suzuki S; Kurono Y; Sugiyama N; Togari H
    Tohoku J Exp Med; 2007 Dec; 213(4):351-9. PubMed ID: 18075239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
    Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
    Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization.
    Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy.
    Westermann CM; Dorland L; Votion DM; de Sain-van der Velden MG; Wijnberg ID; Wanders RJ; Spliet WG; Testerink N; Berger R; Ruiter JP; van der Kolk JH
    Neuromuscul Disord; 2008 May; 18(5):355-64. PubMed ID: 18406615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correcting false positive medium-chain acyl-CoA dehydrogenase deficiency results from newborn screening; synthesis, purification, and standardization of branched-chain C8 acylcarnitines for use in their selective and accurate absolute quantitation by UHPLC-MS/MS.
    Minkler PE; Stoll MSK; Ingalls ST; Hoppel CL
    Mol Genet Metab; 2017 Apr; 120(4):363-369. PubMed ID: 28190699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress.
    Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Exil V; Duran M; Wijburg FA; Wanders RJ; Strauss AW
    Eur J Clin Invest; 2004 Mar; 34(3):191-6. PubMed ID: 15025677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of plasma carnitine and acylcarnitines by high-performance liquid chromatography-tandem mass spectrometry using online solid-phase extraction.
    Morand R; Donzelli M; Haschke M; Krähenbühl S
    Anal Bioanal Chem; 2013 Nov; 405(27):8829-36. PubMed ID: 23995505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of acylcarnitines as their N-demethylated ester derivatives by gas chromatography-chemical ionization mass spectrometry.
    Huang ZH; Gage DA; Bieber LL; Sweeley CC
    Anal Biochem; 1991 Nov; 199(1):98-105. PubMed ID: 1807168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of new medium-chain acylcarnitines present in urine of a patient with medium-chain acyl-CoA dehydrogenase deficiency.
    Libert R; Van Hoof F; Thillaye M; Vincent MF; Nassogne MC; Stroobant V; de Hoffmann E; Schanck A
    J Inherit Metab Dis; 1999 Feb; 22(1):9-18. PubMed ID: 10070613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of supplementation with L-carnitine at a small dose on acylcarnitine profiles in serum and urine and the renal handling of acylcarnitines in a patient with multiple acyl-coenzyme A dehydrogenation defect.
    Yoshino M; Tokunaga Y; Watanabe Y; Yoshida I; Sakaguchi M; Hata I; Shigematsu Y; Kimura M; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(1):73-82. PubMed ID: 12828999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple and unambiguous method for identifying urinary acylcarnitines using gas chromatography--mass spectrometry.
    Lowes S; Rose ME
    Analyst; 1990 May; 115(5):511-6. PubMed ID: 2396741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of urinary acylcarnitines using gas chromatography-mass spectrometry: preliminary clinical applications.
    Lowes S; Rose ME; Mills GA; Pollitt RJ
    J Chromatogr; 1992 Jun; 577(2):205-14. PubMed ID: 1400753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of free carnitine, individual short- and medium-chain acylcarnitines, and total carnitine in plasma by high-performance liquid chromatography.
    Minkler PE; Hoppel CL
    Anal Biochem; 1993 Aug; 212(2):510-8. PubMed ID: 8214594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of urinary carnitine esters in a patient with medium-chain acyl-coenzyme A dehydrogenase deficiency: effect of metabolic state and L-carnitine therapy.
    Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL; Rossi TM; Lebenthal E
    J Pediatr; 1989 Oct; 115(4):577-82. PubMed ID: 2795349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.